NEW HORIZONS GLOBAL LIMITED
New Horizons Global Limited is a Belfast-based B2B ingredient producer that develops DHA-rich algal omega-3 from microalgae for food, beverage, supplement, and medical food manufacturers. The product is sustainably fermented in Europe, carries EFSA and GRAS regulatory clearances, and is sold as a non-marine, solvent-free alternative to fish-oil DHA.
- Company typePrivate
- Founded2008
- HeadquartersBelfast, United Kingdom
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What NEW HORIZONS GLOBAL LIMITED does
New Horizons Global Limited is a privately held, Belfast-based ingredient producer that develops a DHA-rich algal omega-3 sourced from microalgae for use in food, beverage, supplement, and medical food formulations. The company's core product is positioned as a sustainable, non-marine alternative to fish-oil-derived DHA: production is fermentation-based, avoids solvents, requires no heavy metal or PCB removal steps, and yields a non-GMO ingredient with a cleaner taste profile. Manufacturing is conducted in Europe to FSSC 22000 quality standards, and the product carries EFSA approval for the European market and GRAS notification in the United States, giving it regulatory access to the two largest regulated omega-3 markets.
The business operates a B2B ingredient sales model, selling the algal DHA as a bulk input to formulators rather than directly to consumers. Prospective customers contact the company via a single email inbox ([email protected]) to express buying interest, and no public pricing, distribution agreements, or named customer accounts have been disclosed. The company is currently small (1–10 employees) and is updating its website ahead of what it describes as an "exciting" forthcoming announcement, suggesting the product is moving from development toward a broader commercial launch. No funding rounds, management team, or partnership disclosures are available in the input data, which constrains the visibility of its commercial traction to date.
NEW HORIZONS GLOBAL LIMITED firmographics
Firmographics- Name
- NEW HORIZONS GLOBAL LIMITED
- Legal name
- New Horizons Global Limited
- Website
- https://newhorizonsglobal.com
- Company type
- Private
- Founded year
- 2008
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- New Horizons Global Limited is a Belfast-based B2B ingredient producer that develops DHA-rich algal omega-3 from microalgae for food, beverage, supplement, and medical food manufacturers. The product is sustainably fermented in Europe, carries EFSA and GRAS regulatory clearances, and is sold as a non-marine, solvent-free alternative to fish-oil DHA.
- Ownership category
- akta.pro rank
NEW HORIZONS GLOBAL LIMITED industry classification
Industry- Product category
- Nutritional Ingredients
- NAICS
- Fats and Oils Refining and Blending (311225)
- SIC
- Fats & Oils (2070)
- akta.pro primary industry
- Omega-3 & Specialty Lipids (Fish/Algal Oils, EPA/DHA, MCTs, CLA, Phospholipids) (AFAJAKAC)
- akta.pro secondary industries
- Omega-3 & Marine/Algal Lipids (EPA/DHA Oils, Concentrates) (AFAJALAK), Seaweed & Algae Aquaculture (incl. microalgae) (AFAEAAAE)
Keywords
Where NEW HORIZONS GLOBAL LIMITED is headquartered
LocationHeadquarters
- HQ city
- Belfast
- HQ country
- United Kingdom
- HQ region
- Europe
Offices1 record
Markets served
NEW HORIZONS GLOBAL LIMITED business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D
Revenue model
- Algal Omega-3 Ingredient Sales: B2B sale of DHA-rich algal omega-3 as an ingredient to food, beverage, supplement, and medical food manufacturers. The product is positioned as a sustainable, clean-label alternative to fish oil-derived DHA.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels1 record
NEW HORIZONS GLOBAL LIMITED product offering
Product offeringCore offering
New Horizons Global Limited manufactures and sells a DHA-rich algal omega-3 ingredient derived from microalgae through sustainable fermentation. The product is a non-marine alternative to fish oil-derived DHA, produced without solvents and without requiring heavy metal or PCB removal, and is marketed to food, beverage, supplement, and medical food manufacturers.
Product overview
New Horizons Global Limited offers a single unified product: a DHA-rich algal omega-3 ingredient. This sustainable omega-3 supplement is derived from microalgae rather than fish, providing all the benefits of fish oil DHA without the environmental and quality concerns. The product targets food, beverage, supplement, and medical food manufacturers seeking a cleaner, better-tasting omega-3 ingredient.
Differentiator
Problem solved
Functional benefit
Products and services
- DHA Rich Algal Omega-3
Quantifiable outcome
- Sustainable production with zero fish harm
Companies that use NEW HORIZONS GLOBAL LIMITED
Customer profileSegments4 records
Ideal customer profiles3 records
NEW HORIZONS GLOBAL LIMITED technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
NEW HORIZONS GLOBAL LIMITED partnerships and signals
Strategic signalScale indicators1 record
Recent moves5 records
Expansion highlights5 records
NEW HORIZONS GLOBAL LIMITED competitors and assessment
Company assessmentDirect peers
- Royal DSM (Algal Omega-3 heritage brand - life'sDHA OMEGA-3): Legacy standalone reference for DSM's Martek-derived life'sDHA product family, the original major commercial algal DHA ingredient brand. Served as the template against which New Horizons Global's positioning (algal, sustainable, EFSA/GRAS, food/beverage/supplement/medical food applications) is articulated.
- DSM-Firmenich (Martek life'sDHA): Global leader in algal DHA via its Martek life'sDHA franchise, the dominant incumbent supplying DHA-rich oil from microalgae into infant formula, food, beverage, and supplement manufacturers worldwide. Directly comparable product, customer base, and regulatory positioning, but at massively greater scale and sales coverage.
- KD Pharma Group: Specialist omega-3 ingredient manufacturer (fish and algal oils) supplying EPA/DHA concentrates to the nutraceutical and pharmaceutical industries. Closely comparable in product, regulatory profile (GOED membership, pharma-grade oils), and B2B ingredient model.
- Corbion: Dutch specialty food ingredients company that markets AlgaeOmega, an algal DHA ingredient targeting food and supplement applications. Closely comparable in technology (microalgae-derived DHA), customer verticals, and B2B ingredient positioning.
- Aker BioMarine: Norwegian supplier of omega-3 ingredients (Superba krill oil and through partnerships, microalgae-derived DHA) into supplement and functional food manufacturers. Directly comparable B2B ingredient model and target customers, with alternative sustainable-marine sourcing narrative.
Broad incumbents
- Stepan Lipid Nutrition: US-based lipid ingredient supplier producing omega-3 oils (including algal-source options) for nutritional and functional food applications. Overlaps with New Horizons Global on product format (refined omega-3 oils) and target customer segments, but within a broader surfactant and specialty chemicals portfolio.
- Croda International: UK-listed specialty ingredients company supplying lipid nutrition, including omega-3 PUFAs and high-purity DHA, into supplement, infant nutrition, and personal care manufacturers. Comparable customer base and end-markets but as part of a broad specialty chemicals portfolio.
- BASF: Through its Nutrition & Health division (formerly Cognis), BASF supplies DHA-rich oils to the food, beverage, and supplement industry, including algal-source options. Overlaps in product and customer base but as part of a much broader nutrition and chemicals portfolio.
- Archer Daniels Midland (ADM): Global nutrition and agri-processing major with a substantial plant- and algae-based omega-3 ingredient portfolio through its Nutrition division. Sells DHA into food, beverage, and supplement manufacturers and overlaps with New Horizons Global on customer verticals, though within a much larger portfolio.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
NEW HORIZONS GLOBAL LIMITED social profiles
Digital presenceNEW HORIZONS GLOBAL LIMITED compliance and trust
Trust signalCompliance3 records
NEW HORIZONS GLOBAL LIMITED financial estimates
Financial estimateRevenue estimate
Valuation estimate
NEW HORIZONS GLOBAL LIMITED leadership team
Management profileNumber of profiles
NEW HORIZONS GLOBAL LIMITED funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
NEW HORIZONS GLOBAL LIMITED M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about NEW HORIZONS GLOBAL LIMITED
What does NEW HORIZONS GLOBAL LIMITED do?
New Horizons Global Limited manufactures and sells a DHA-rich algal omega-3 ingredient derived from microalgae through sustainable fermentation. The product is a non-marine alternative to fish oil-derived DHA, produced without solvents and without requiring heavy metal or PCB removal, and is marketed to food, beverage, supplement, and medical food manufacturers.
Is NEW HORIZONS GLOBAL LIMITED a public or private company?
NEW HORIZONS GLOBAL LIMITED is a private company. It is classified as unknown and is currently operating.
When was NEW HORIZONS GLOBAL LIMITED founded?
NEW HORIZONS GLOBAL LIMITED was founded in 2008. It employs 1 to 10 people.
Where is NEW HORIZONS GLOBAL LIMITED based?
NEW HORIZONS GLOBAL LIMITED is headquartered in Belfast, United Kingdom, in the Europe region.
How does NEW HORIZONS GLOBAL LIMITED make money?
One revenue line is on record: algal Omega-3 Ingredient Sales.
Who are NEW HORIZONS GLOBAL LIMITED's main competitors?
Direct peers on record are Royal DSM (Algal Omega-3 heritage brand - life'sDHA OMEGA-3), DSM-Firmenich (Martek life'sDHA), KD Pharma Group, Corbion and Aker BioMarine. Broad incumbents are Stepan Lipid Nutrition, Croda International, BASF and Archer Daniels Midland (ADM).
Does NEW HORIZONS GLOBAL LIMITED have an API?
No public API is recorded for NEW HORIZONS GLOBAL LIMITED.
What industry is NEW HORIZONS GLOBAL LIMITED in?
NEW HORIZONS GLOBAL LIMITED's product category is Nutritional Ingredients. Its primary akta.pro industry code is AFAJAKAC, Omega-3 & Specialty Lipids (Fish/Algal Oils, EPA/DHA, MCTs, CLA, Phospholipids), with a secondary code of AFAJALAK, Omega-3 & Marine/Algal Lipids (EPA/DHA Oils, Concentrates). Its NAICS code is 311225 and its SIC code is 2070.